Welcome to NQMC. Skip directly to: Search Box, Navigation, Content.


Brief Summary


TITLE

Chronic stable coronary artery disease (CAD): percentage of patients who were prescribed lipid lowering therapy.

SOURCE(S)

  • American College of Cardiology, American Heart Association, Physician Consortium for Performance Improvement™. Clinical performance measures: chronic stable coronary artery disease. Tools developed by physicians for physicians. Chicago (IL): American Medical Association (AMA); 2005. 8 p. [18 references]

Measure Domain

PRIMARY MEASURE DOMAIN

SECONDARY MEASURE DOMAIN

Does not apply to this measure

Brief Abstract

DESCRIPTION

This measure is used to assess the percentage of patients with chronic stable coronary artery disease (CAD) who were prescribed lipid lowering therpy (based on current American College of Cardiology/American Heart Association [ACC/AHA] guidelines).

RATIONALE

According to National Heart, Lung, and Blood (NHLBI) guidelines, the low-density lipoprotein cholesterol (LDL-C) treatment goal is less than 100 mg/dl. Persons with established coronary heart disease (CHD) who have a baseline LDL-C greater than or equal to 130 mg/dl should be started on a cholesterol-lowering drug simultaneously with therapeutic lifestyle changes and control of nonlipid risk factors.

PRIMARY CLINICAL COMPONENT

Coronary artery disease (CAD); lipid lowering therapy

DENOMINATOR DESCRIPTION

All patients with coronary artery disease (CAD)

NUMERATOR DESCRIPTION

Patients from the denominator who were prescribed lipid lowering therpy

DATA SOURCE

Medical record

Identifying Information

ORIGINAL TITLE

Drug therapy for lowering LDL-cholesterol.

MEASURE COLLECTION

MEASURE SET NAME

SUBMITTER

American Medical Association on behalf of the American College of Cardiology, the American Heart Association, and the Physician Consortium for Performance Improvement

DEVELOPER

American College of Cardiology - Medical Specialty Society
American Heart Association
Physician Consortium for Performance Improvement

ENDORSER

National Quality Forum

INCLUDED IN

Ambulatory Care Quality Alliance

ADAPTATION

Measure was not adapted from another source.

RELEASE DATE

2001 Aug

REVISION DATE

2005 Aug

MEASURE STATUS

This is the current release of the measure.

This measure updates a previous version: American College of Cardiology, American Heart Association, Physician Consortium for Performance Improvement. Clinical performance measures. Chronic stable coronary artery disease. Chicago (IL): American Medical Association (AMA); 2003. 8 p.

SOURCE(S)

  • American College of Cardiology, American Heart Association, Physician Consortium for Performance Improvement™. Clinical performance measures: chronic stable coronary artery disease. Tools developed by physicians for physicians. Chicago (IL): American Medical Association (AMA); 2005. 8 p. [18 references]

MEASURE AVAILABILITY

COMPANION DOCUMENTS

The following are available:

For further information, please contact AMA staff by e-mail at cqi@ama-assn.org.

NQMC STATUS

This NQMC summary was completed by ECRI on September 26, 2003. The information was verified by the measure developer on January 28, 2004. This NQMC summary was updated by ECRI on September 28, 2005.

COPYRIGHT STATEMENT

Physician Performance Measures (Measures) and related data specifications, developed by the Physician Consortium for Performance Improvement (the Consortium), are intended to facilitate quality improvement activities by physicians.

These Measures are intended to assist physicians in enhancing quality of care. Measures are designed for use by any physician who manages the care of a patient for a specific condition or for prevention. These performance Measures are not clinical guidelines and do not establish a standard of medical care. The Consortium has not tested its Measures for all potential applications. The Consortium encourages the testing and evaluation of its Measures.

Measures are subject to review and may be revised or rescinded at any time by the Consortium. The Measures may not be altered without the prior written approval of the Consortium. Measures developed by the Consortium, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and American Medical Association, on behalf of the Consortium. Neither the Consortium nor its members shall be responsible for any use of these Measures.

THE MEASURES ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.

© 2005 American Medical Association. All Rights Reserved.